Growth Metrics

Healthstream (HSTM) EBIAT (2016 - 2025)

Healthstream (HSTM) has disclosed EBIAT for 16 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 48.17% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Dec 2025, down 8.34% year-over-year, with the annual reading at $18.3 million for FY2025, 8.32% down from the prior year.
  • EBIAT for Q4 2025 was $2.5 million at Healthstream, down from $6.1 million in the prior quarter.
  • The five-year high for EBIAT was $6.1 million in Q3 2025, with the low at -$387000.0 in Q4 2021.
  • Average EBIAT over 5 years is $3.6 million, with a median of $3.8 million recorded in 2022.
  • The sharpest move saw EBIAT plummeted 141.93% in 2021, then soared 732.82% in 2022.
  • Over 5 years, EBIAT stood at -$387000.0 in 2021, then skyrocketed by 732.82% to $2.4 million in 2022, then surged by 87.42% to $4.6 million in 2023, then increased by 6.51% to $4.9 million in 2024, then plummeted by 48.17% to $2.5 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at $2.5 million, $6.1 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.